Geron and GE Healthcare, a division of General Electric, are developing and commercializing cellular assay products derived from human embryonic stem cells for use in drug discovery, development and toxicity screening.

FORBES

General Electric ( GE - news - people ), are developing and commercializing cellular assay products derived from human embryonic stem cells for use in drug discovery, development and toxicity screening.

FORBES: Four Standard-Bearers For Stem Cell Therapies

Dr Veenstra said the system was still in development, so it was not yet suitable for a routine screening programme.

BBC: NEWS | Health | Test detects early ovarian cancer